These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2660047)

  • 1. Mitoxantrone therapy of advanced adenocarcinoma of the endometrium. A phase II trial.
    Runge HM; Meerpohl HG; Pfleiderer A
    Onkologie; 1989 Apr; 12(2):102-3. PubMed ID: 2660047
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitoxantrone for carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group.
    Muss HB; Bundy BN; DiSaia PJ; Ehrlich CE
    Cancer Treat Rep; 1987 Feb; 71(2):217-8. PubMed ID: 3802120
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of mitoxantrone in advanced or metastatic endometrial carcinoma.
    Boadle DJ; Tattersall MH
    Aust N Z J Obstet Gynaecol; 1987 Nov; 27(4):341-2. PubMed ID: 3453676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone in advanced and/or recurrent endometrial carcinoma.
    Veenhof KH; George M; Forni M; Tumolo S; Rotmensz N; Vermorken JB
    Eur J Cancer; 1990; 26(5):650. PubMed ID: 2144760
    [No Abstract]   [Full Text] [Related]  

  • 5. Megestrol acetate in the management of advanced endometrial carcinoma.
    Wait RB
    Obstet Gynecol; 1973 Jan; 41(1):129-36. PubMed ID: 4682608
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of advanced endometrial cancer with hydroxyprogesterone caproate.
    Reifenstein EC
    Gynecol Oncol; 1974 Aug; 2(2-3):377-414. PubMed ID: 4616884
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: a Southwest Oncology Group study.
    Taylor SA; Fleming T; Von Hoff DD; McCracken JD; Bukowski RM; Talley RW; Natale RB; Guy JT; Samlowski WE; Costanzi JH
    Invest New Drugs; 1990 Feb; 8(1):77-80. PubMed ID: 2188928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone in adenocarcinoma of the endometrium: a Southwest Oncology Group Study.
    Hilgers RD; Von Hoff DD; Stephens RL; Boutselis JG; Rivkin SE
    Cancer Treat Rep; 1985 Nov; 69(11):1329-30. PubMed ID: 4092197
    [No Abstract]   [Full Text] [Related]  

  • 9. Progestogens in the treatment of carcinoma of the endometrium.
    Kennedy BJ
    Surg Gynecol Obstet; 1968 Jul; 127(1):103-14. PubMed ID: 5657772
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
    Kline RC; Freedman RS; Jones LA; Atkinson EN
    Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
    [No Abstract]   [Full Text] [Related]  

  • 11. Epirubicin in advanced endometrial adenocarcinoma: a phase II study of the Grupo Ginecologico Español para el Tratamiento Oncologico (GGETO).
    Calero F; Asins-Codoñer E; Jimeno J; Rodriguez Escudero F; Mendaña J; Iglesias J; Matía F; Armas A; Díaz-Castellanos R; Garzón J
    Eur J Cancer; 1991; 27(7):864-6. PubMed ID: 1834118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen therapy in advanced/recurrent endometrial carcinoma.
    Quinn MA; Campbell JJ
    Gynecol Oncol; 1989 Jan; 32(1):1-3. PubMed ID: 2909443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
    Henderson IC; Allegra JC; Woodcock T; Wolff S; Bryan S; Cartwright K; Dukart G; Henry D
    J Clin Oncol; 1989 May; 7(5):560-71. PubMed ID: 2468745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyprogesterone caproate therapy in advanced endometrial cancer.
    Reifenstein EC
    Cancer; 1971 Mar; 27(3):485-502. PubMed ID: 5549492
    [No Abstract]   [Full Text] [Related]  

  • 15. Progestin therapy in lesions of the endometrium.
    Wentz WB
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II evaluation of mitoxantrone in advanced non anaplastic thyroid cancer.
    Schlumberger M; Parmentier C
    Bull Cancer; 1989; 76(4):403-6. PubMed ID: 2752182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of mitoxantrone in advanced gastric cancer.
    Goldenberg A; Kelsen D; Benedetto P
    Oncology; 1988; 45(4):273-5. PubMed ID: 3290754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral progestin therapy for metastatic adenocarcinoma of the endometrium.
    Puckett TG; Merrill JA
    J Okla State Med Assoc; 1967 Sep; 60(9):506-11. PubMed ID: 6076025
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognosis of endometrial carcinoma.
    Cheon HK
    Obstet Gynecol; 1969 Nov; 34(5):680-4. PubMed ID: 5348672
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; Delgado G; Louka M
    Cancer Treat Rep; 1983; 67(7-8):737-8. PubMed ID: 6871892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.